In re BioAge Labs, Inc., Securities Litigation

1 2 3 4 5 6 7 UNITED STATES DISTRICT COURT 8 NORTHERN DISTRICT OF CALIFORNIA 9 IN RE BIOAGE LABS, INC., 10 Case No. 25-cv-00196-RS SECURITIES LITIGATION 11 ORDER GRANTING DEFENDANTS' 12 MOTION TO DISMISS WITH LEAVE TO AMEND 13 14 15 The Southeast Pennsylvania Transportation Authority (“SEPTA”), on behalf of itself and a 16 putative class of similarly situated investors, sued BioAge Labs and ten of its corporate officers 17 under two provisions of the Securities Act of 1933, 15 U.S.C. §§ 77k, o. SEPTA alleges that, in 18 the run-up to its initial public offering, BioAge misled investors by…